Form 4: Astrana Health Director Exercises Options, Sells Shares

Astrana Health Director David Schmidt exercised 20,000 stock options and subsequently sold 4,269 shares for tax withholding, increasing his direct beneficial ownership to 31,494 common shares.

Summary

• David Schmidt, a Director of Astrana Health, Inc. (ASTH), reported changes in his beneficial ownership.
• On January 13, 2026, Schmidt exercised 20,000 stock options to acquire Common Stock at an exercise price of $5.79 per share.
• Concurrently, he disposed of 4,269 shares of Common Stock at a price of $27.12 per share to cover tax withholding obligations related to the option exercise.
• Following these transactions, Schmidt directly beneficially owns 31,494 shares of Astrana Health Common Stock.
• This total includes 6,449 shares of restricted stock, which are scheduled to vest on the earlier of June 11, 2026, or the date of the Issuer's 2026 annual meeting of stockholders.
• The exercised stock options were fully vested and exercisable prior to the transaction.

Sentiment

Score: 6

Explanation: The exercise of stock options by a director generally signals confidence in the company's future prospects, as it converts potential equity into actual ownership. However, the concurrent sale of shares for tax withholding is a routine event and does not necessarily reflect a negative outlook.

Positives

• Director David Schmidt exercised 20,000 stock options, indicating a conversion of potential ownership into actual shares, which can be seen as a sign of confidence in the company's future.
• The exercise price of $5.79 per share is significantly lower than the disposition price of $27.12 per share, suggesting a substantial in-the-money value for the options.

Negatives

• A portion of the acquired shares (4,269 shares) was immediately sold to cover tax withholding, which reduces the net increase in the director's direct beneficial ownership.

Future Outlook

The filing notes that 6,449 shares of restricted stock will vest on the earlier of June 11, 2026, or the date of the Issuer's 2026 annual meeting of stockholders. This indicates a future vesting event for a portion of the director's holdings.

Industry Context

This filing is a standard insider transaction report and does not provide information to analyze broader industry trends or competitors. It reflects an individual director's equity activity within Astrana Health, Inc.

Related Party Transactions

• The reported transactions involve a director of the company, which constitutes a related party transaction in the context of insider trading regulations.

Stakeholder Impact

• Shareholders may view the option exercise as a positive signal of insider confidence, although the tax-related sale is a common practice.

Next Steps

• Vesting of 6,449 shares of restricted stock on the earlier of June 11, 2026, or the date of Astrana Health's 2026 annual meeting of stockholders.

Key Dates

Keywords

Astrana Health, ASTH, Form 4, insider transaction, stock options, beneficial ownership, director, equity, common stock, share sale, tax withholding